| __timestamp | Cytokinetics, Incorporated | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 72429000 |
| Thursday, January 1, 2015 | 19667000 | 78634000 |
| Friday, January 1, 2016 | 27823000 | 75374000 |
| Sunday, January 1, 2017 | 36468000 | 92157000 |
| Monday, January 1, 2018 | 31282000 | 93326000 |
| Tuesday, January 1, 2019 | 39610000 | 103132000 |
| Wednesday, January 1, 2020 | 52820000 | 110171000 |
| Friday, January 1, 2021 | 96803000 | 218817000 |
| Saturday, January 1, 2022 | 177977000 | 233827000 |
| Sunday, January 1, 2023 | 173612000 | 267194000 |
In pursuit of knowledge
In the ever-evolving landscape of the pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Lantheus Holdings, Inc. and Cytokinetics, Incorporated from 2014 to 2023. Over this period, Lantheus Holdings consistently outpaced Cytokinetics in SG&A spending, reflecting its expansive operational scale. Notably, Lantheus saw a 270% increase in SG&A expenses, peaking in 2023, while Cytokinetics experienced a 900% surge, highlighting its aggressive growth strategy. The year 2021 marked a significant leap for both companies, with Lantheus's expenses nearly doubling from 2020, and Cytokinetics's expenses increasing by 83%. This trend underscores the strategic investments both companies are making to bolster their market positions. As the industry continues to innovate, these financial insights provide a window into the strategic priorities of these pharmaceutical giants.
Novo Nordisk A/S or Lantheus Holdings, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Cytokinetics, Incorporated
Alnylam Pharmaceuticals, Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Cytokinetics, Incorporated
Who Optimizes SG&A Costs Better? Genmab A/S or Cytokinetics, Incorporated
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.